Analysts have been eager to weigh in on the Healthcare sector with new ratings on Caribou Biosciences (CRBU – Research Report) and Mettler-Toledo (MTD – Research Report).
Caribou Biosciences (CRBU)
In a report issued on May 10, Yigal Nochomovitz from Citi maintained a Buy rating on Caribou Biosciences, with a price target of $30.00. The company’s shares closed last Friday at $3.54, close to its 52-week low of $3.44.
According to TipRanks.com, Nochomovitz is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Caribou Biosciences with a $20.00 average price target, implying a 445.0% upside from current levels. In a report issued on May 7, RBC Capital also maintained a Buy rating on the stock with a $19.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Mettler-Toledo (MTD)
In a report issued on May 10, Patrick B Donnelly from Citi maintained a Sell rating on Mettler-Toledo, with a price target of $1200.00. The company’s shares closed last Friday at $1510.25, close to its 52-week high of $1514.82.
According to TipRanks.com, Donnelly is a 3-star analyst with an average return of
Currently, the analyst consensus on Mettler-Toledo is a Moderate Sell with an average price target of $1206.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CRBU:
- Caribou Biosciences reports Q1 EPS (46c), consensus (41c)
- Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
- Caribou Biosciences Advances with FDA Clearance and New Trials
- FDA clears Caribou’s IND application for CB-010 to treat lupus and ERL
